Although CD147 does not directly interact with EGFR, its expression and secretion significantly influence the therapeutic efficacy of EGFR-targeted IgA antibodies by modulating neutrophil function in HNSCC (52). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.